J&J helps Goldman's slow start for M&A in 2001

Goldman Sachs is set to boost its mergers and acquisitions ranking after acting for US pharmaceuticals company Johnson & Johnson on its $12.3bn (€13.7bn) acquisition of Alza.

Although Johnson & Johnson declined to give the names of its advisers, sources close to Goldman Sachs privately confirm that the bank acted on the transaction.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump